The Immune System – News and Features

The company has named Chris A. Rallis, Executive-in-Residence at Pappas Ventures, and Anthony A. DiTonno, President and Chief Executive Officer of Neurogesx Inc., to serve as members of the company's Board of Directors. The addition of these two directors increases the Board to five members.

NIH publishes the data online in the Dec. 19 issue of The Journal of Clinical Investigation.

The company announced that investigational medicine GLPG0778, which is part of its immuno- inflammatory alliance with GlaxoSmithKline, has shown selective effects on a biomarker in a Phase I Proof-of-Mechanism study in healthy volunteers.

Ovarian cancer -- the most severe of all gynecological cancers -- claims the lives of over 1,750 Canadian women every year. And, just as each woman fighting the disease is unique, so are their cancers.

Masao Matsuoka awarded 2011 retrovirology prize.

Framework agreement initiated with three Compugen-discovered peptides mutually selected for further development by BioLineRx.

Under the terms of the agreement, Affymetrix will acquire eBioscience for $330 million in cash subject to certain customary adjustments. The transaction is subject to customary closing conditions.

Companies to help emerging nations develop their own manufacturing capabilities for essential biopharmaceuticals, reducing reliance on imports.

The companies announced that they have entered into a worldwide collaboration to jointly develop and commercialize Reata’s portfolio of second-generation oral antioxidant inflammation modulators (AIMs).

Pharmalink also acquires equipment and technologies from Archimedes Pharma to manufacture TARGIT capsules for Nefecon.